HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kirsten K Ness Selected Research

Daunorubicin (Cerubidine)

6/2019Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity.
11/2015Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kirsten K Ness Research Topics

Disease

79Neoplasms (Cancer)
05/2022 - 08/2005
18Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 09/2006
11Obesity
01/2021 - 09/2010
8Hypertension (High Blood Pressure)
03/2021 - 02/2007
8Osteosarcoma (Osteogenic Sarcoma)
01/2020 - 02/2011
7Sarcoma (Soft Tissue Sarcoma)
05/2022 - 04/2005
7Cardiomyopathies (Cardiomyopathy)
01/2021 - 09/2011
7Leukemia
01/2021 - 04/2005
7Chronic Disease (Chronic Diseases)
06/2020 - 02/2008
6Frailty
10/2021 - 01/2016
5Peripheral Nervous System Diseases (PNS Diseases)
01/2022 - 05/2015
5Hodgkin Disease (Hodgkin's Disease)
06/2021 - 04/2005
5Cardiovascular Diseases (Cardiovascular Disease)
06/2021 - 11/2012
4Pain (Aches)
10/2020 - 06/2014
4Fatigue
06/2020 - 02/2008
4Overweight
01/2020 - 01/2016
4Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2019 - 04/2005
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2019 - 09/2006
4Dyslipidemias (Dyslipidemia)
11/2012 - 09/2006
3Genetic Risk Score
01/2022 - 01/2020
3Heart Failure
01/2021 - 02/2015
3Stroke (Strokes)
01/2021 - 01/2018
3Wilms Tumor (Wilm's Tumor)
10/2020 - 04/2005
3Osteonecrosis (Kienbock's Disease)
10/2020 - 01/2014
3Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 11/2017
3Insulin Resistance
01/2020 - 04/2011
3Hypothyroidism
12/2019 - 12/2007
3Cardiotoxicity
06/2019 - 01/2015
3Brain Neoplasms (Brain Tumor)
01/2017 - 04/2005
3Hearing Loss (Hearing Impairment)
04/2016 - 09/2005
3Neuroblastoma
04/2013 - 04/2005
2Infections
05/2022 - 01/2019
2Sarcopenia
11/2021 - 12/2019
2Diabetes Mellitus
01/2021 - 01/2020
2Lymphoma (Lymphomas)
10/2020 - 07/2018
2Hypogonadism (Hypergonadotropic Hypogonadism)
10/2020 - 06/2019
2Sleepiness
06/2020 - 02/2008
2Cognitive Dysfunction
12/2019 - 01/2019
2Seizures (Absence Seizure)
12/2019 - 12/2014
2Precocious Puberty
12/2019 - 03/2016
2Carcinoma (Carcinomatosis)
01/2019 - 04/2005
2Pulmonary Hypertension
01/2018 - 02/2013
2Second Primary Neoplasms (Neoplasms, Second)
11/2017 - 11/2014
2Emphysema
12/2016 - 02/2014
2Asthma (Bronchial Asthma)
12/2016 - 02/2014
2Chronic Cough
12/2016 - 02/2014
2Fibrosis (Cirrhosis)
12/2016 - 02/2014
1Ventricular Remodeling
12/2021
1Hypertriglyceridemia
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Infarction (Infarctions)
01/2021
1Hypercholesterolemia
01/2021
1Long Term Adverse Effects
01/2021
1Myocardial Infarction
01/2021

Drug/Important Bio-Agent (IBA)

15AnthracyclinesIBA
12/2021 - 04/2011
6Biomarkers (Surrogate Marker)IBA
11/2021 - 08/2012
6Growth Hormone (Somatotropin)IBA
06/2019 - 09/2006
5Cisplatin (Platino)FDA LinkGeneric
03/2021 - 09/2005
4Vincristine (Oncovin)FDA LinkGeneric
01/2022 - 02/2012
4Alkylating AgentsIBA
11/2021 - 10/2014
4GlucocorticoidsIBA
11/2021 - 05/2015
4HDL LipoproteinsIBA
01/2020 - 08/2012
3Dihydrotachysterol (AT 10)IBA
10/2021 - 12/2013
3PlatinumIBA
01/2021 - 04/2013
3Biological ProductsIBA
10/2020 - 01/2018
3Pharmaceutical PreparationsIBA
01/2020 - 01/2012
3Triglycerides (Triacylglycerol)IBA
01/2020 - 08/2012
3ORALIT (ORS)IBA
12/2019 - 10/2014
3Methotrexate (Mexate)FDA LinkGeneric
02/2016 - 02/2012
3CholesterolIBA
05/2014 - 08/2012
3Antidepressive Agents (Antidepressants)IBA
01/2012 - 09/2010
2Mitochondrial DNA (mtDNA)IBA
11/2021 - 01/2018
2Hormones (Hormone)IBA
10/2020 - 02/2015
26-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
12/2019 - 03/2016
2Doxorubicin (Adriamycin)FDA LinkGeneric
06/2019 - 11/2015
2Daunorubicin (Cerubidine)FDA LinkGeneric
06/2019 - 11/2015
2Follicle Stimulating Hormone (Follitropin)FDA Link
01/2017 - 02/2015
2Oxygen (Dioxygen)IBA
12/2016 - 02/2014
2SteroidsIBA
01/2016 - 10/2012
2ApolipoproteinsIBA
10/2013 - 08/2012
2Lipoprotein(a)IBA
10/2013 - 08/2012
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
10/2013 - 08/2012
2C-Reactive ProteinIBA
10/2013 - 08/2012
2Fibrinogen (Factor I)FDA Link
10/2013 - 08/2012
1Calcineurin InhibitorsIBA
03/2021
1Carboplatin (JM8)FDA LinkGeneric
03/2021
1IfosfamideFDA LinkGeneric
03/2021
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2021
1pro-brain natriuretic peptide (1-76)IBA
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
1Troponin T (Troponin T1)IBA
01/2021

Therapy/Procedure

66Therapeutics
01/2022 - 10/2007
25Radiotherapy
12/2021 - 05/2008
22Drug Therapy (Chemotherapy)
05/2022 - 01/2008
12Aftercare (After-Treatment)
05/2022 - 01/2011
7Surgical Amputation (Amputations)
05/2022 - 04/2005
6Cell Transplantation
01/2019 - 09/2004
4Physical Therapy Modalities (Physical Therapy Technique)
01/2022 - 03/2011
4Resistance Training
10/2021 - 01/2011
3Limb Salvage
05/2022 - 01/2014